Spruce Bio's ticker is and the CUSIP is E5209E109. A total of 1 filers reported holding Spruce Bio in Q1 2021. The put-call ratio across all filers is - and the average weighting 10.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,101,000 | -13.1% | 1,792,518 | 0.0% | 0.99% | -1.9% |
| Q1 2022 | $3,567,000 | -55.2% | 1,792,518 | 0.0% | 1.01% | -47.5% |
| Q4 2021 | $7,959,000 | -25.7% | 1,792,518 | 0.0% | 1.93% | -20.7% |
| Q3 2021 | $10,719,000 | -46.6% | 1,792,518 | 0.0% | 2.43% | -60.8% |
| Q2 2021 | $20,076,000 | -32.5% | 1,792,518 | 0.0% | 6.21% | -39.6% |
| Q1 2021 | $29,738,000 | -31.0% | 1,792,518 | 0.0% | 10.27% | -30.3% |
| Q4 2020 | $43,074,000 | – | 1,792,518 | – | 14.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,792,518 | $29,738,000 | 10.27% |